The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage

Cooperation of germ line JAK2 mutations E846D and R1063H in hereditary erythrocytosis with megakaryocytic atypia

(2016) K. Kapralova et al.   BLOOD

Neuroprotective Effects of an Erythropoietin-Derived Peptide in PC1 2 Cells under Oxidative Stress

(2016) Seung-Jun Yoo et al.   CNS & Neurological Disorders-Drug Targets

Emerging EPO and EPO receptor regulators and signal transducers

(2015) D. Kuhrt et al.   BLOOD

Stroke Care Within the Golden Hour—Reply

(2015) Martin Ebinger et al.   JAMA Neurology

Stroke Care Within the Golden Hour

(2015) Kyle Fischer et al.   JAMA Neurology

Erythropoietin: Emerging Role of Erythropoietin in Neonatal Neuroprotection

(2014) Vijayeta Rangarajan et al.   PEDIATRIC NEUROLOGY

Evidence That Erythropoietin Modulates Neuroinflammation through Differential Action on Neurons, Astrocytes, and Microglia

(2014) Wesley S. Bond et al.   Frontiers in Immunology

Excitotoxicity and stroke: Identifying novel targets for neuroprotection

(2013) Ted Weita Lai et al.   PROGRESS IN NEUROBIOLOGY

NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors

(2013) X Zhou et al.   Cell Death & Disease

Excitotoxicity: Bridge to various triggers in neurodegenerative disorders

(2012) Ankita Mehta et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Recombinant human erythropoietin attenuates neuronal apoptosis and cognitive defects via JAK2/STAT3 signaling in experimental endotoxemia

(2012) Ting-Fa Zhou et al.   JOURNAL OF SURGICAL RESEARCH

Treatment with Nasal Neuro-EPO Improves the Neurological, Cognitive, and Histological State in a Gerbil Model of Focal Ischemia

(2011) Yamila Rodríguez Cruz et al.   TheScientificWorldJOURNAL

Neuroprotection in experimental stroke in the rat with an IgG–erythropoietin fusion protein

(2010) Ailing Fu et al.   BRAIN RESEARCH

Erythropoiesis-Stimulating Agents — Time for a Reevaluation

(2010) Ellis F. Unger et al.   NEW ENGLAND JOURNAL OF MEDICINE

The “Golden Hour” and Acute Brain Ischemia

(2010) Jeffrey L. Saver et al.   STROKE

Mitochondria, oxidative metabolism and cell death in stroke

(2009) Neil R. Sims et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Apoptotic Mechanisms After Cerebral Ischemia

(2009) Brad R.S. Broughton et al.   STROKE

Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke

(2009) Hannelore Ehrenreich et al.   STROKE

Mechanisms underlying the loss of mitochondrial membrane potential in glutamate excitotoxicity

(2008) Andrey Y. Abramov et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

The non-haematopoietic biological effects of erythropoietin

(2008) Murat O. Arcasoy   BRITISH JOURNAL OF HAEMATOLOGY

Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin

(2008) N Byts et al.   CELL DEATH AND DIFFERENTIATION

Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated Anemia

(2008) Charles L. Bennett   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Erythropoietin improves brain mitochondrial function in rats after traumatic brain injury

(2008) Ye Xiong et al.   NEUROLOGICAL RESEARCH

Neuroprotection with or without erythropoiesis; sometimes less is more

(2007) L Torup   BRITISH JOURNAL OF PHARMACOLOGY